✦ LIBER ✦

A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix

✍ Scribed by Robert E. Slayton; John A. Blessing; Mark Rettenmaier; Harrison Ball

Book ID: 104651488
Publisher: Springer US
Year: 1989
Tongue: English
Weight: 251 KB
Volume: 7
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00173764

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II clinical trial of diaziquone

A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus

✍ Robert E. Slayton; John A. Blessing; Katherine Look; Barrie Anderson 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 115 KB

Phase II trial of weekly locoregional hy

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

✍ Ron C. Rietbroek; Marten S. Schilthuis; Piet J. M. Bakker; Jan D. P. van Dijk; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 3 views

## Phase II Trial of Weekly Locoregional Hyperthermia and Cisplatin in Patients with a Previously Irradiated Recurrent Carcinoma of the Uterine Cervix BACKGROUND. The biologic rationale for combining cisplatin with locoregional Ron C

Phase I-II clinical trial of californium

Phase I-II clinical trial of californium-252. Treatment of stage IB carcinoma of the cervix

✍ Yosh Maruyama; John R. Vannagell; Justine Yoneda; Elvis Donaldson; Holly Gallion 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Thalidomide in the treatment of patients

Thalidomide in the treatment of patients with hepatocellular carcinoma : A Phase II trial

✍ Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Ajay K. Nooka; Isaac I. Schn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that pote

Phase II study of carboplatin and liposo

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

✍ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti

Phase II clinical trial of SKI-2053R, a

Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

✍ Noe K. Kim; Seock-Ah Im; Dong-Wan Kim; Moon H. Lee; Chul W. Jung; Eun K. Cho; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

BACKGROUND. SKI-2053R (SK Chemicals, Kyungki-Do, South Korea) is a new platinum derivative with antitumor activity against various cell lines, including cisplatin-resistant tumor cell lines. Preclinical studies have suggested that it is less nephrotoxic than cisplatin. This study evaluated the effic